Literature DB >> 14766271

Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer.

John P Geisler1, Daniel F Schraith, Kelly J Manahan, Joel I Sorosky.   

Abstract

We present two patients who developed necrotizing enterocolitis following their first cycle of chemotherapy for epithelial ovarian/peritoneal cancer. After optimal cytoreductive surgery, both women received gemcitabine as part of a chemotherapy protocol. One patient developed necrotizing enterocolitis, 1 day after chemotherapy and the other 8 days after chemotherapy. The first patient succumbed to the enterocolitis despite aggressive supportive care. The second patient succumbed despite both aggressive supportive care and surgical intervention. Pathologic review for both patients revealed a drug induced vasculitis causing necrotizing enterocolitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766271     DOI: 10.1016/j.ygyno.2003.10.050

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  [Cerebral vasculitis associated with gemcitabine].

Authors:  P Schmorl; A Heer-Sonderhoff; R Vosshenrich; S Conrad
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

2.  Neutropenic enterocolitis: current issues in diagnosis and management.

Authors:  Marta L Davila
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

3.  Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect.

Authors:  Toby A Eyre; Sarah Gooding; Ishita Patel; Niall Moore; Chris Hatton; Graham P Collins
Journal:  Int J Hematol       Date:  2014-03-02       Impact factor: 2.490

4.  The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis.

Authors:  B K Kleinschmidt-DeMasters; Denise M Damek
Journal:  J Neurooncol       Date:  2009-07-16       Impact factor: 4.130

Review 5.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.